Literature DB >> 8132777

Immune responses to human immunodeficiency virus type 1 in exposed but uninfected individuals: protection or chance?

D J Looney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8132777      PMCID： PMC293991          DOI： 10.1172/JCI117096

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

1.  Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion.

Authors:  R Cheingsong-Popov; C Panagiotidi; M Ali; S Bowcock; P Watkins; A Aronstam; M Wassef; J Weber
Journal:  AIDS Res Hum Retroviruses       Date:  1990-09       Impact factor: 2.205

2.  Antibodies to the nef protein and to nef peptides in HIV-1-infected seronegative individuals.

Authors:  J C Ameisen; B Guy; S Chamaret; M Loche; Y Mouton; J L Neyrinck; J Khalife; C Leprevost; G Beaucaire; C Boutillon
Journal:  AIDS Res Hum Retroviruses       Date:  1989-06       Impact factor: 2.205

3.  Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.

Authors:  A Hoffenbach; P Langlade-Demoyen; G Dadaglio; E Vilmer; F Michel; C Mayaud; B Autran; F Plata
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

4.  Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.

Authors:  A Ranki; K Järvinen; S L Valle; P Nurmilaakso; K Krohn
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection.

Authors:  F O Gombert; W Blecha; M Tähtinen; A Ranki; S Pfeifer; W Tröger; R Braun; N Müller-Lantzsch; G Jung; H Rübsamen-Waigmann
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

6.  Relevance of anti-nef antibody detection as an early serologic marker of human immunodeficiency virus infection.

Authors:  E Bahraoui; A Benjouad; J M Sabatier; J P Allain; Y Laurian; L Montagnier; J C Gluckman
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

7.  Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers.

Authors:  R Cheynier; P Langlade-Demoyen; M R Marescot; S Blanche; G Blondin; S Wain-Hobson; C Griscelli; E Vilmer; F Plata
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

8.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

Authors:  M Clerici; J V Giorgi; C C Chou; V K Gudeman; J A Zack; P Gupta; H N Ho; P G Nishanian; J A Berzofsky; G M Shearer
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

9.  Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population.

Authors:  D B Brettler; M Somasundaran; A F Forsberg; E Krause; J L Sullivan
Journal:  Blood       Date:  1992-11-01       Impact factor: 22.113

10.  Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

Authors:  P Langlade-Demoyen; N Ngo-Giang-Huong; F Ferchal; E Oksenhendler
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808
View more
  2 in total

Review 1.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 2.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.